New drug to treat brain atrophy brain dementia to be available

recently learned that the investment of 130 million yuan to develop, produce and is listed as a three-type new drug for brain dementia, brain atrophy " Vizhi" red deer ginseng tablets will soon be fully launched, but also has the privilege of protecting the varieties of Chinese medicineof the SixthHospital of Beijing Medical University, XiyuanHospital
of the ChineseInstitute of Traditional Chinese Medicine
, andaffiliated hospital of LiaoningChinese medicineHospital, the hospital sedithas and determined that the red deer ginseng tablets have significant effect on theof brain disease seditutology, brain atrophy and other
diseases, indicating that China has made a major breakthrough in the treatment ofdiseases such as brain dementia and brain atrophyIt is understood that brain dementia, brain atrophy and otherdiseases
has been the international medical community for the difficult and difficult disease, with a long cycle, after the recovery of difficult, drag down family members and so on Experts said that for brain atrophy, brain dementia and other diseases, the current risk of Western medicine and surgical treatment is difficult to predict, and often to patients and their families to bring a huge financial burden The inventor of the "Weizhi" brand red deer ginseng film is professor of neurology expert ShoYuShu, according to the introduction, as early as 1996, Professor Ho Yushu accidentally found that the combination of deer antlers and ginseng stem leaves can activate brain cells, amplify ingenuating nerve replacement function, this discovery became a turning point in the fight against brain dementia and brain atrophy However, china's extraction of deer antlers difficult to maintain activity, in order to overcome difficulties, Professor Ho traveled to the United States, with the help of the United States high-tech purification technology, and make it to activate brain cells and neuroreplacement function increased 20 times That year, the research achievements that became a sensation in the medical field were patented in the United States (Shi Lei) (reproduced from the Journal of Medicine and Economics)